Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

2.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

PMID:
15358046
3.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

4.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

5.

Managing dyslipidemia in the high-risk patient.

Stein EA.

Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.

PMID:
11900720
6.
7.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
8.

Perspectives on low-density lipoprotein cholesterol goal achievement.

Catapano AL.

Curr Med Res Opin. 2009 Feb;25(2):431-47. doi: 10.1185/03007990802631438 . Review.

PMID:
19192988
9.

Cholesterol lowering in atherosclerosis.

Brown WV.

Am J Cardiol. 2000 Aug 24;86(4B):29H-32H. Review.

PMID:
11021253
10.

Intensive statin therapy for Indians: Part-I. Benefits.

Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K.

Indian Heart J. 2011 May-Jun;63(3):211-27. Review.

PMID:
22734339
11.

Diabetes and cardiovascular disease.

Howard BV, Magee MF.

Curr Atheroscler Rep. 2000 Nov;2(6):476-81. Review.

PMID:
11122781
12.

Low density lipoprotein cholesterol: is lower better?

Leiter LA.

Can J Cardiol. 2000 Jan;16 Suppl A:20A-2A. Review.

PMID:
10653927
13.

Assessing the results: phase 1 hyperlipidemia outcomes in 27 health plans.

Latts LM.

Am J Med. 2001 Apr 16;110 Suppl 6A:17S-23S. Review.

PMID:
11311193
14.

Cardiovascular basis for cholesterol therapy.

Rackley CE.

Cardiol Rev. 2000 Mar-Apr;8(2):124-31. Review.

PMID:
11174884
15.

Management of hypercholesterolemia in older persons for the prevention of cardiovascular disease.

Aronow WS, Frishman WH.

Cardiol Rev. 2010 May-Jun;18(3):132-40. doi: 10.1097/CRD.0b013e3181c29571. Review.

PMID:
20395698
16.

Achieving cholesterol targets: how well are we doing?

Cruickshank JM.

J Am Osteopath Assoc. 2011 Apr;111(4 Suppl 3):eS3-6. Review.

PMID:
21593472
17.
18.

Pharmacological strategies for lowering LDL cholesterol: statins and beyond.

Brautbar A, Ballantyne CM.

Nat Rev Cardiol. 2011 May;8(5):253-65. doi: 10.1038/nrcardio.2011.2. Epub 2011 Feb 15. Review.

PMID:
21321561
20.

Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, Brown WV, Cromwell WC, Goldberg RB, McKenney JM, Remaley AT, Sniderman AD, Toth PP, Tsimikas S, Ziajka PE, Maki KC, Dicklin MR.

J Clin Lipidol. 2011 Sep-Oct;5(5):338-67. doi: 10.1016/j.jacl.2011.07.005.

PMID:
21981835
Items per page

Supplemental Content

Write to the Help Desk